共 31 条
[1]
Cancer Pain, (1994)
[2]
Ahmedzai S., Brooks D., Transdermal fentanyl versus sustained-release oral morphine in cancer pain, J Pain Symptom Manage, 13, pp. 254-261, (1997)
[3]
Empfehlungen zur therapie von Tumorschmerzen, 93, SUPPL., (1996)
[4]
Ashby M.A., Martin P., Jackson K.A., Opioid substitution to reduce adverse effects in cancer pain management, Med J Aust, 170, pp. 68-71, (1999)
[5]
Body J.J., Lossignol D., Ronson A., The concept of rehabilitation of cancer patients, Curr Opin Oncol, 9, pp. 332-340, (1997)
[6]
Caraceni A., Portenoy R.K., An international survey of cancer pain characteristics and syndroms, Pain, 82, pp. 263-274, (1999)
[7]
Leitlinie zur medikamentosen Schmerztherapie, pp. 375-394, (2000)
[8]
DuPen S.L., DuPen A.R., Polissar N., Et al., Implementing guidelines for cancer pain management, J Clin Oncol, 17, pp. 361-370, (1999)
[9]
Ensink F.B.M., Bautz M.T., Weyland W., Et al., The influence of 'opioid-myths' on the attitudes of German physicians treating pain in cancer patients, pp. 231-232, (1999)
[10]
Grond S., Radbruch L., Meuser T., Sabatowski R., Loick G., Lehmann K.A., Assessment and treatment of neutropathic cancer pain following WHO guidelines, Pain, 79, pp. 15-20, (1999)